HOXA7 Expression Is an Independent Prognostic Biomarker in Esophageal Squamous Cell Carcinoma
Genes · 2024
DOI: 10.3390/genes15111430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Jennifer Vieira Gomes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Toxicologia e Biologia Molecular, Departamento de Bioquímica, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro 20550-01…. Hauptthemen laut MEDLINE: Homeodomain Proteins, Esophageal Squamous Cell Carcinoma, Biomarkers, Tumor, Esophageal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.
Abstract (Originalsprache)
Background/Objectives: Homeobox (HOX) genes encode conserved transcription factors essential for tissue and organ development and cellular differentiation. In humans, these genes are organized into four clusters: HOXA, HOXB, HOXC, and HOXD. While HOX genes have been extensively studied in cancer biology, their roles in esophageal squamous cell carcinoma (ESCC) remain poorly understood. Given the increasing incidence and high mortality rate of ESCC, exploring the molecular drivers of this tumor is urgent.
Methods
Therefore, this study investigated the mutational landscape and expression profiles of HOX genes in ESCC and their differentially expressed targets using ESCC data from The Cancer Genome Atlas (TCGA) and two independent transcriptome datasets.
Results
We found that copy number alterations and single nucleotide variations were rare, while seven HOX genes (HOXA2, HOXA7, HOXB13, HOXC9, HOXC10, HOXC13, and HOXD10) were significantly differentially expressed in ESCC compared to paired non-malignant mucosa. Further analysis identified 776 potential HOX target genes differentially expressed in ESCC, many of which are involved in critical cancer pathways such as PI3K-AKT, cell cycle regulation, and epithelial–mesenchymal transition (EMT). The HOXA7 overexpression was associated with poor overall survival rates in ESCC. This finding opens new possibilities for targeted therapies, offering hope for improved patient outcomes.
Conclusions
Thus, this study underscored the pivotal role of HOX gene dysregulation in ESCC and classified HOXA7 as a potential prognostic biomarker in this tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Toxicologia e Biologia Molecular, Departamento de Bioquímica, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro 20550-013, RJ, Brazil.
- Programa de Carcinogênese Molecular, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.
- Beneficência Portuguesa de São Paulo, São Paulo 01323-001, SP, Brazil.
- Programa de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.
ORCID-Profile: Pedro Nicolau-Neto, Lilian Brewer Lisboa, Paulo Thiago de Souza-Santos, Sheila Coelho Soares-Lima, Tatiana de Almeida Simão
Förderung
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Zitieren
APA
Gomes, J. V., Nicolau-Neto, P., de Almeida, J. N., Lisboa, L. B., de Souza-Santos, P. T., Ribeiro-Pinto, L. F., Soares-Lima, S. C., & Simão, T. A. (2024). HOXA7 Expression Is an Independent Prognostic Biomarker in Esophageal Squamous Cell Carcinoma. Genes. https://doi.org/10.3390/genes15111430
Vancouver
Gomes JV, Nicolau-Neto P, de Almeida JN, Lisboa LB, de Souza-Santos PT, Ribeiro-Pinto LF, et al. HOXA7 Expression Is an Independent Prognostic Biomarker in Esophageal Squamous Cell Carcinoma. Genes. 2024. doi:10.3390/genes15111430
BibTeX
@article{Gomes2024,
author = {Gomes, Jennifer Vieira and Nicolau-Neto, Pedro and de Almeida, Júlia Nascimento and Lisboa, Lilian Brewer and de Souza-Santos, Paulo Thiago and Ribeiro-Pinto, Luis Felipe and Soares-Lima, Sheila Coelho and Simão, Tatiana de Almeida},
title = {HOXA7 Expression Is an Independent Prognostic Biomarker in Esophageal Squamous Cell Carcinoma},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15111430}
}
EUVIMED